Copyright
©The Author(s) 2023.
World J Hepatol. Jul 27, 2023; 15(7): 867-882
Published online Jul 27, 2023. doi: 10.4254/wjh.v15.i7.867
Published online Jul 27, 2023. doi: 10.4254/wjh.v15.i7.867
Figure 2 Mechanisms showing the role of gut microbiota in metabolic-associated fatty liver disease.
FXR: Farnesoid X receptor; TGR5: Takeda G protein-coupled; MAFLD: Metabolic-associated fatty liver disease; BA: Bile acid; LPS: Lipopolysaccharides; TNF-α: Tumor-necrosis factor alpha; TLR: Toll like receptor.
- Citation: Guo GJ, Yao F, Lu WP, Xu HM. Gut microbiome and metabolic-associated fatty liver disease: Current status and potential applications. World J Hepatol 2023; 15(7): 867-882
- URL: https://www.wjgnet.com/1948-5182/full/v15/i7/867.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i7.867